Baker IDI Heart and Diabetes Institute, PO Box 6492 St. Kilda Road Central, Melbourne, Victoria 8008, Australia.
J Appl Physiol (1985). 2010 Feb;108(2):227-37. doi: 10.1152/japplphysiol.00832.2009. Epub 2009 Nov 25.
Sympathetic nervous system responses typically are regionally differentiated, with activation in one outflow sometimes accompanying no change or sympathetic inhibition in another. Regional sympathetic activity is best studied in humans by recording from postganglionic sympathetic efferents (multiunit or single fiber recording) and by isotope dilution-derived measurement of organ-specific norepinephrine release to plasma (regional "norepinephrine spillover"). Evidence assembled in this review indicates that sympathetic nervous system abnormalities are crucial in the development of cardiovascular disorders, notably heart failure, essential hypertension, disorders of postural circulatory control causing syncope, and "psychogenic heart disease," heart disease attributable to mental stress and psychiatric illness. These abnormalities involve persistent, adverse activation of sympathetic outflows to the heart and kidneys in heart failure and hypertension, episodic or ongoing cardiac sympathetic activation in psychogenic heart disease, and defective sympathetic circulatory reflexes in disorders of postural circulatory control. An important goal for clinical scientists is translation of knowledge of pathophysiology, such as this, into better treatment for patients. The achievement of this "mechanisms-to-management" transition is at differing stages of development with the different conditions. Clinical translation is mature in cardiac failure, knowledge of cardiac neural pathophysiology having led to introduction of beta-adrenergic blockers, an effective therapy. With essential hypertension, perhaps we are on the cusp of effective translation, with recent successful testing of selective catheter-based renal sympathetic nerve ablation in patients with resistant hypertension, an intervention firmly based on demonstration of activation of the renal sympathetic outflow. With psychogenic heart disease and postural syncope syndromes, knowledge of the neural pathophysiology is emerging, but clinical translation remains for the future.
交感神经系统反应通常具有区域性差异,一种传出神经的激活有时伴随着另一种传出神经的无变化或抑制。在人类中,通过记录节后交感传出神经(多单位或单纤维记录)和通过同位素稀释法测量特定器官去甲肾上腺素释放到血浆中的方法(区域“去甲肾上腺素溢出”)来研究局部交感活性。本综述中收集的证据表明,交感神经系统异常在心血管疾病的发展中至关重要,特别是心力衰竭、原发性高血压、导致晕厥的姿势循环控制障碍以及“心因性心脏病”,这些疾病归因于精神压力和精神疾病的心脏病。这些异常涉及心力衰竭和高血压中持续的、不利的心脏和肾脏传出交感神经激活,心因性心脏病中阵发性或持续的心脏交感神经激活,以及姿势循环控制障碍中交感循环反射的缺陷。临床科学家的一个重要目标是将这种病理生理学知识转化为更好的患者治疗方法。这种“机制到管理”的转变在不同的情况下处于不同的发展阶段。在心力衰竭方面,临床转化已经成熟,心脏神经病理生理学的知识已经导致了β肾上腺素能阻滞剂的引入,这是一种有效的治疗方法。在原发性高血压方面,我们可能正在走向有效的转化,最近对耐药性高血压患者进行的选择性导管肾交感神经消融术的成功测试就是一个很好的例子,这种干预措施是基于对肾交感传出神经激活的证实。对于心因性心脏病和姿势性晕厥综合征,神经病理生理学的知识正在出现,但临床转化仍有待未来。